Literature DB >> 20702643

Resistance to rabies virus infection conferred by the PMLIV isoform.

Danielle Blondel1, Sabrina Kheddache, Xavier Lahaye, Laurent Dianoux, Mounira K Chelbi-Alix.   

Abstract

Various reports implicate PML and PML nuclear bodies (NBs) in an intrinsic antiviral response targeting diverse cytoplasmic replicating RNA viruses. PML conjugation to the small ubiquitin-like modifier (SUMO) is required for its localization within NBs. PML displays antiviral effects in vivo, as PML deficiency renders mice more susceptible to infection with the rhabdovirus vesicular stomatitis virus (VSV). Cells derived from these mice are also more sensitive to infection with rabies virus, another member of the rhabdovirus family. Alternative splicing from a single gene results in the synthesis of several PML isoforms, and these are classified into seven groups, designated PMLI to -VII. We report here that expression of PMLIV or PMLIVa, which is missing exon 5, inhibited viral mRNA and protein synthesis, leading to a reduction in viral replication. However, the expression of other nuclear isoforms (PMLI to -VI) and cytoplasmic PMLVIIb failed to impair viral production. This antiviral effect required PMLIV SUMOylation, as it was not observed with PMLIV 3KR, in which the lysines involved in SUMO conjugation were mutated. Thus, PMLIV and PMLIVa may exert this isoform-specific function through interaction with specific NB protein partners via their common C-terminal region.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702643      PMCID: PMC2950589          DOI: 10.1128/JVI.01286-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

Review 2.  PML protein isoforms and the RBCC/TRIM motif.

Authors:  K Jensen; C Shiels; P S Freemont
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

Review 3.  Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot.

Authors:  D Negorev; G G Maul
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

4.  The function of PML in p53-dependent apoptosis.

Authors:  A Guo; P Salomoni; J Luo; A Shih; S Zhong; W Gu; P P Pandolfi
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

5.  PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.

Authors:  T Regad; A Saib; V Lallemand-Breitenbach; P P Pandolfi; H de Thé; M K Chelbi-Alix
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

6.  Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies.

Authors:  Danielle Blondel; Tarick Regad; Nicolas Poisson; Benjamen Pavie; Francis Harper; Pier Paolo Pandolfi; Hugues De Thé; Mounira K Chelbi-Alix
Journal:  Oncogene       Date:  2002-11-14       Impact factor: 9.867

7.  The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.

Authors:  A Kentsis; E C Dwyer; J M Perez; M Sharma; A Chen; Z Q Pan; K L Borden
Journal:  J Mol Biol       Date:  2001-09-28       Impact factor: 5.469

8.  Effects of promyelocytic leukemia protein on virus-host balance.

Authors:  Weldy V Bonilla; Daniel D Pinschewer; Paul Klenerman; Valentin Rousson; Mirella Gaboli; Pier P Pandolfi; Rolf M Zinkernagel; Maria S Salvato; Hans Hengartner
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 9.  Role and fate of PML nuclear bodies in response to interferon and viral infections.

Authors:  T Regad; M K Chelbi-Alix
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

10.  PML regulates p53 stability by sequestering Mdm2 to the nucleolus.

Authors:  Rosa Bernardi; Pier Paolo Scaglioni; Stephan Bergmann; Henning F Horn; Karen H Vousden; Pier Paolo Pandolfi
Journal:  Nat Cell Biol       Date:  2004-06-13       Impact factor: 28.824

View more
  29 in total

1.  Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus.

Authors:  Sonja Schmid; David Sachs; Benjamin R tenOever
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

Review 2.  TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity.

Authors:  Ricardo Rajsbaum; Adolfo García-Sastre; Gijs A Versteeg
Journal:  J Mol Biol       Date:  2013-12-12       Impact factor: 5.469

3.  The type I interferon response bridles rabies virus infection and reduces pathogenicity.

Authors:  Damien Chopy; Claudia N Detje; Mireille Lafage; Ulrich Kalinke; Monique Lafon
Journal:  J Neurovirol       Date:  2011-07-30       Impact factor: 2.643

Review 4.  The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1.

Authors:  Shuai Wang; Jing Long; Chun-fu Zheng
Journal:  Protein Cell       Date:  2012-04-28       Impact factor: 14.870

5.  Focal adhesion kinase is involved in rabies virus infection through its interaction with viral phosphoprotein P.

Authors:  Baptiste Fouquet; Jovan Nikolic; Florence Larrous; Hervé Bourhy; Christoph Wirblich; Cécile Lagaudrière-Gesbert; Danielle Blondel
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

6.  Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.

Authors:  Mohamed Ali Maroui; Mathieu Pampin; Mounira K Chelbi-Alix
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

7.  Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.

Authors:  Mohamed Ali Maroui; Sabrina Kheddache-Atmane; Faten El Asmi; Laurent Dianoux; Muriel Aubry; Mounira K Chelbi-Alix
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  Genetic and evolutionary characterization of RABVs from China using the phosphoprotein gene.

Authors:  Lihua Wang; Hui Wu; Xiaoyan Tao; Hao Li; Simon Rayner; Guodong Liang; Qing Tang
Journal:  Virol J       Date:  2013-01-07       Impact factor: 4.099

Review 9.  Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.

Authors:  Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Mediators Inflamm       Date:  2012-12-18       Impact factor: 4.711

10.  Differential Roles of PML Isoforms.

Authors:  Sébastien Nisole; Mohamed Ali Maroui; Xavier H Mascle; Muriel Aubry; Mounira K Chelbi-Alix
Journal:  Front Oncol       Date:  2013-05-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.